Donate to Illuminate Contact TSF
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin Visit us on Tiktok

Choose Your Language:

TSF Participates in India’s Workshop on the National Rare Disease Policy

Posted by: The Sumaira Foundation in News & Announcements

On June 13, 2023, TSF’s India Ambassador, Clarinda Cerejo participated in a multi-stakeholder workshop on the national rare disease policy of India in Delhi, India.

The workshop was organized by one of India’s leading patient advocates, Dr. Ratna Devi and her team, and was attended by government representatives, medical and industry professionals working in rare diseases, and fellow rare disease advocates. 

Dr. Devi kicked off the event by explaining the challenges that rare disease patients and advocacy groups face and our expectations of the government. 

Dr. L. Swasticharan, Director General of Health Services, Ministry of Health, shared initiatives the Indian government is leading to increase reach and access for rare diseases. Many significant strides have been made in the last two years:

Medical experts leading CoE efforts discussed the ground realities and challenges that doctors, patients, and administrators face while navigating the complexities that are inevitable in trying to operationalize a policy directive for such a large population. 

Finally, working groups discussed innovative ideas to 

Our recommendations will be formally proposed to the government, and we look forward to a continued productive dialogue. 

While NMOSD and MOGAD are not currently listed in the national rare disease policy of India, TSF stands by affected patients. This meeting was an important first step in our advocacy efforts in India, and we look forward to these diseases soon being included in the India policy. 

Jai Hind!

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.